Divis Laboratories Ltd Share Price Today - Live Blog for March 27, 2026

Divis Laboratories Ltd stock price decreased by -0.47%, with the current market value at 5986.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Divis Laboratories Ltd witnessed a substantial 0.17% increase in its share price and is currently trading at 6024.50. This remarkable performance has caught the eye of investors.

Divis Laboratories Ltd's stock has surged by 0.17%, and it is currently trading at 6024.50. Additionally, the stock maintains a PE ratio of 64.3900, while the industry PE is 32.0845.

Divis Laboratories Ltd's share price rallied by 0.03%, reaching the current market price of 6016.50. This surge is indicative of the stock's recent positive performance.

The stock of Divis Laboratories Ltd is making significant strides, boasting a 0.03% increase and currently trading at 6016.50 per share. This upward trajectory is turning heads in the market.

Divis Laboratories Ltd observed a remarkable 0.06% surge in its share price and is presently trading at 6018.00. The increased investor interest is driving this surge.

Divis Laboratories Ltd's shares saw an increase of 0.06%, reaching the current market price of 6018.00. This development underscores the stock's growing popularity.

Divis Laboratories Ltd experienced a substantial 0.35% boost in its share price and has garnered significant attention from the market. It's now trading at 6035.50, making it an appealing option for investors.

Following a noteworthy 0.35% increase, Divis Laboratories Ltd's shares are now trading at 6035.50. When it comes to valuation, this stock has a PE ratio of 64.3900, with the industry PE ratio at 32.0845.

In recent times, Divis Laboratories Ltd witnessed a decline of -0.34% in its share price, and it currently trades at 5994.00 per share. The stock has an ROE of 16.1228 and debt to equity ratio of 0.0058.

Divis Laboratories Ltd stock price decreased by -0.34%, with the current market value at 5994.00 per share. Investors are assessing the stock's potential for recovery and future growth prospects.